A Survival Analysis of Psychostimulant Prescriptions in New South Wales from 1990 to 2010.
J Child Adolesc Psychopharmacol. 2015 Jul 28;
Authors: Lambert MC, Reid R, Prosser B, Bussing R
Abstract
OBJECTIVE: Psychostimulant medication is considered a mainstay in the treatment of attention-deficit/hyperactivity disorder (ADHD); however, research suggests that the typical duration of medication treatment for children and youth may be <3 years. The purpose of this study was to evaluate the psychostimulant treatment persistence for children and adolescents in New South Wales, Australia.
METHODS: This study used survival analysis to assess duration of medication treatment on a large administrative database of children and youth from New South Wales, Australia. Several models were fit to evaluate differences in survival rates among decades (1990-1999 vs. 2000-2010), gender, and age.
RESULTS: Results showed that: 1) Overall median treatment time (i.e., median survival time) was 1.96 years (99% CI=1.93, 1.99); 2) there were small, but significant changes over time in duration of treatment; 3) females had shorter treatment duration than males; and 4) there were relatively large differences in treatment duration across age groups.
CONCLUSIONS: These results indicate that the majority of children and youth receive medication treatment for only a small portion of childhood/adolescence, and that there are differential patterns in treatment duration across age groups.
PMID: 26218772 [PubMed – as supplied by publisher]
